What qualifies: Price breaks a meaningful level, cannot hold above it, returns to the prior range and shows evidence that buyers are no longer defending the breakout.

Distinguish failure from a normal retest

Healthy breakouts often revisit the pivot before continuing. The key difference is acceptance. A constructive retest tends to hold near the breakout level, contract in volume and recover. A failed breakout spends meaningful time back below the pivot, closes weakly or attempts a reclaim that sellers reject.

Require evidence in sequence

  1. Defined breakout: The original resistance or pivot is obvious.
  2. Loss of acceptance: Price closes back inside the old range rather than briefly dipping below it.
  3. Weak recovery: A bounce stalls below—or only briefly above—the former pivot.
  4. Relative weakness: The stock underperforms its sector or the broad market.
  5. Participation: Selling volume expands or rebound volume dries up.

Choose the entry that matches the evidence

An aggressive entry may occur on a decisive close back below the pivot. A more patient entry waits for the failed reclaim or lower high, which can provide a clearer stop but risks missing the move. Neither entry is automatically superior; the choice should be consistent with the stock’s liquidity and gap risk.

Define invalidation before targeting downside

The cleanest invalidation is usually above the failed reclaim high or above a sustained recovery of the breakout level. If price regains the pivot with volume and begins holding above it, the failure thesis is weakened. Do not widen the stop simply because short interest or valuation still looks high.

Map downside logically

Potential targets should come from prior support, the middle or bottom of the old range, an unfilled gap or a measured move—not an arbitrary profit goal. Compare potential reward with the distance to invalidation before entering.

Check squeeze and event risk

  • High short interest, utilization or expensive borrow
  • Thin float or limited liquidity
  • Heavy call activity near important strikes
  • Earnings, investor days, FDA decisions or court rulings
  • A broader market or sector reversal that could lift weak names

A technically attractive short can still be a poor trade if one overnight event can overwhelm the planned risk. Options may define risk, but high implied volatility and time decay can make puts expensive.

What makes us pass

We avoid shorting a breakout merely because it looks extended. We also pass when support is too close, the invalidation is unclear, liquidity is poor or the stock repeatedly squeezes on small headlines. Selectivity matters more on the short side because losses can accelerate quickly.

Confirm a breakout retest without chasing →Build the invalidation plan →Review a losing trade without hindsight →Browse all EdgeTrack Insights →

Educational content only. Short selling and options involve substantial risk, including rapid losses and gap risk.